The Latest Breaking News on Pharma

Advocates say multiple strategies must be used to lower prices as new drugs threaten to bankrupt health system

Bioverativ formed a perfect double bottom, a key chart pattern for growth stock hunters, and broke out ahead of its big 61% gain on news it's being bought by Sanofi.

Starboard has reached out to former Pfizer CEO Ian Read and ex-finance chief Frank D'Amelio, and both have expressed interest in supporting the activist investor's turnaround efforts, reports said.

The warning follows last week's U.S. Department of Justice (DOJ) indictment of illegal online pharmacies selling counterfeit prescription pills laced with fentanyl and methamphetamine to tens of thousands of people in the U.S., leading to at least nine deaths.

The healthcare industry is set for growth due to the growing demand for quality healthcare services and ongoing advancements in medical technology. Hence, investors might consider investing in healthcare stocks, Johnson & Johnson (JNJ), AbbVie (ABBV), and Thermo Fisher Scientific (TMO) for safe and steady growth. Read more….

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

SPX Technologies is Stock Of The Day as the HVAC innovator capitalizes on growth opportunities serving data centers, drugmakers and more.

Argenx stock is in a buy zone on the stock market today after a recent breakout and the biotech leader is poised to hit new highs.

The cuts will affect about 1% of its workforce.